{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:03:10Z","timestamp":1790492590563,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Novartis Oncology and Bristol-Myers Squibb"},{"name":"\u201cSport et Collection\u201d"},{"name":"\u201cRotary Club de Civray\u201d"},{"name":"Association Vaincre le Cancer \u2013 NRB, Villejuif, France"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.leukres.2017.07.007","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T17:17:15Z","timestamp":1501089435000},"page":"94-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs)"],"prefix":"10.1016","volume":"60","author":[{"given":"Djamel","family":"Aggoune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Sorel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Goujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"H\u00e9rault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"R\u00e9a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Legros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyacinthe","family":"Johnson-Ansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rousselot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Cayssials","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Guerci-Bresler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Bennaceur-Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Chomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.07.007_bib0005","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ajh.23560","article-title":"Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors","volume":"88","author":"Falchi","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2017.07.007_bib0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1200\/JCO.2013.49.9020","article-title":"Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV","volume":"32","author":"Hehlmann","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2017.07.007_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.007_bib0020","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.007_bib0025","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","article-title":"Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells","volume":"109","author":"Jorgensen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.007_bib0030","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.leukres.2017.07.007_bib0035","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease","volume":"118","author":"Chomel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.007_bib0040","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.007_bib0045","first-page":"7","article-title":"The relationship between the spleen colony-forming cell and the haemopoietic stem cell","volume":"4","author":"Schofield","year":"1978","journal-title":"Blood Cells"},{"key":"10.1016\/j.leukres.2017.07.007_bib0050","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1242\/jcs.074112","article-title":"The haematopoietic stem cell niche at a glance","volume":"124","author":"Lo Celso","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.leukres.2017.07.007_bib0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2013.10.002","article-title":"Regulation of hematopoietic stem cells by bone marrow stromal cells","volume":"35","author":"Anthony","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.leukres.2017.07.007_bib0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/328342a0","article-title":"Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia","volume":"328","author":"Gordon","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2017.07.007_bib0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","article-title":"Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia","volume":"21","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2017.07.007_bib0070","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood-2009-01-202606","article-title":"The leukemic stem cell niche: current concepts and therapeutic opportunities","volume":"114","author":"Lane","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.007_bib0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.leukres.2017.07.007_bib0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ccr.2011.05.007","article-title":"Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia","volume":"19","author":"Schmidt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2017.07.007_bib0085","doi-asserted-by":"crossref","first-page":"35293","DOI":"10.18632\/oncotarget.9182","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation","volume":"7","author":"Chomel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2017.07.007_bib0090","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.bbrc.2005.05.203","article-title":"Osteopontin is upregulated by BCR-ABL","volume":"333","author":"Flamant","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2017.07.007_bib0095","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bcp.2010.04.003","article-title":"The bone marrow microenvironment as a sanctuary for minimal residual disease in CML","volume":"80","author":"Nair","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.leukres.2017.07.007_bib0100","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/2221278a0","article-title":"Chromosome pattern of bone marrow fibroblasts in patients with chronic granulocytic leukaemia","volume":"222","author":"Maniatis","year":"1969","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.leukres.2017.07.007_bib0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.leu.2404505","article-title":"Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone [letter]","volume":"21","author":"Di Ianni","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.07.007_bib0110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"M\u00e9ndez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2017.07.007_bib0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-immunol-032712-095919","article-title":"Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine","volume":"31","author":"Frenette","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.leukres.2017.07.007_bib0120","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/ijc.23611","article-title":"Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma","volume":"123","author":"Kawase","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.leukres.2017.07.007_bib0125","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1158\/0008-5472.CAN-10-3228","article-title":"Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression","volume":"71","author":"Hoshino","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2017.07.007_bib0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2012.04.158","article-title":"Tumor promoting effect of podoplanin-positive fibroblasts is mediated by enhanced RhoA activity","volume":"422","author":"Ito","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2017.07.007_bib0135","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.3892\/mmr.2016.5009","article-title":"Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment","volume":"13","author":"Lee","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.leukres.2017.07.007_bib0140","doi-asserted-by":"crossref","first-page":"25993","DOI":"10.1074\/jbc.M702327200","article-title":"Involvement of the snake toxin receptor CLEC-2 in podoplanin-mediated platelet activation, by cancer cells","volume":"282","author":"Suzuki-Inoue","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2017.07.007_bib0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MBC.0b013e328365776f","article-title":"Assessment of changes in membrane properties of platelets from patients with chronic myeloid leukaemia in different stages of the disease","volume":"25","author":"Popov","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.leukres.2017.07.007_bib0150","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/scd.2008.0335","article-title":"Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells","volume":"18","author":"Liu","year":"2009","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.leukres.2017.07.007_bib0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molcel.2012.06.020","article-title":"Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells","volume":"47","author":"Tsai","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.leukres.2017.07.007_bib0160","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1038\/sj.onc.1206443","article-title":"Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival","volume":"22","author":"Widlund","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2017.07.007_bib0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1126\/science.1099593","article-title":"Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche","volume":"307","author":"Nishimura","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.leukres.2017.07.007_bib0170","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2353\/ajpath.2008.071030","article-title":"Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines","volume":"172","author":"Bock","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.leukres.2017.07.007_bib0175","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2013-05-501460","article-title":"Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression","volume":"122","author":"Laperrousaz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.007_bib0180","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/(SICI)1097-4644(19990315)72:4<570::AID-JCB12>3.0.CO;2-W","article-title":"Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation","volume":"72","author":"Phinney","year":"1999","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.leukres.2017.07.007_bib0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2017.07.007_bib0190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","article-title":"Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate","volume":"17","author":"Zhang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2017.07.007_bib0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2184.2007.00438.x","article-title":"Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro","volume":"40","author":"Fierro","year":"2007","journal-title":"Cell Prolif."},{"key":"10.1016\/j.leukres.2017.07.007_bib0200","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1182\/blood-2007-07-104281","article-title":"Long-term imatinib therapy promotes bone formation in CML patients","volume":"111","author":"Fitter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.07.007_bib0205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.exphem.2008.12.008","article-title":"Effects of imatinib mesylate in osteoblastogenesis","volume":"37","author":"Tibullo","year":"2009","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2017.07.007_bib0210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.leukres.2014.02.011","article-title":"Decreased frequency, but normal functional integrity of mesenchymal stromal cells derived from untreated and imatinib-treated chronic myeloid leukemia patients","volume":"38","author":"Estrada-Gonz\u00e1lez","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.07.007_bib0215","doi-asserted-by":"crossref","first-page":"16070","DOI":"10.18632\/oncotarget.7445","article-title":"Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation","volume":"7","author":"Carrasco-Ram\u00edrez","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2017.07.007_bib0220","doi-asserted-by":"crossref","first-page":"25438","DOI":"10.1038\/srep25438","article-title":"Nanog, Oct4 and Tet1 interplay in establishing pluripotency","volume":"6","author":"Olariu","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T12:08:26Z","timestamp":1620994106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617304721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":44,"alternative-id":["S0145212617304721"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.07.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs)","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}